{"id":11097,"date":"2022-11-22T16:00:09","date_gmt":"2022-11-22T10:30:09","guid":{"rendered":"https:\/\/www.tickertape.in\/blog\/?p=11097"},"modified":"2022-11-22T16:08:52","modified_gmt":"2022-11-22T10:38:52","slug":"strides-pharma-counter-striving-for-excellence","status":"publish","type":"post","link":"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/","title":{"rendered":"Strides Pharma: Counter Striving for Excellence?"},"content":{"rendered":"\n<p>Wonderful time in the market. We are witnessing the stock-specific movement, which will likely continue. It would absolutely make sense to keep this strategy in mind because the <a href=\"https:\/\/www.tickertape.in\/blog\/stock-market-index\/\">index<\/a> is reaching near the highs. Today, I shared one more counter, which is from the pharmaceutical segment, Strides Pharma, offering the best risk-reward and available at a huge discount.<\/p>\n\n\n\n<iframe loading=\"lazy\" title=\"smallcase embed\" id=\"iframe-ZDRUZJE4\" data-cardsize=\"big\" style=\"display: flex;width: 500px !important;min-height: 300px !important;min-width: 500px !important;padding: 0;border: 1px solid #dde0e4;border-radius: 4px;box-shadow: rgba(0, 0, 0, 0.1) 0px 2px 12px 0px;background: url(https:\/\/www.gateway-tt.in\/assets\/tickertape-loader.svg) no-repeat center center;background-size: 72px\" src=\"https:\/\/www.gateway-tt.in\/trade?id=iframe-ZDRUZJE4&#038;orderConfig=%5B%7B%22quantity%22%3A10%2C%22ticker%22%3A%22STAR%22%7D%5D&#038;cardsize=big&#038;withSearch=true&#038;withTT=true\" onload=\"(function() { if (window.scEmbedController) return; var s = document.createElement(\"script\"); s.setAttribute(\"src\", \"https:\/\/www.gateway-tt.in\/assets\/embed.js\"); document.body.appendChild(s); })()\" width=\"500\" height=\"300\" > Loading widget for STAR <\/iframe>\n\n\n\n<p>Let&#8217;s dive deep into the different time frame charts and understand the observations.&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_66_1 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Monthly-Price-action\" title=\"Monthly: Price action\">Monthly: Price action<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-Price-and-volume-action\" title=\"Weekly: Price and volume action\">Weekly: Price and volume action<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-Price-and-Fibonacci\" title=\"Weekly: Price and Fibonacci\">Weekly: Price and Fibonacci<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Monthly-Price-and-RSI\" title=\"Monthly: Price and RSI\">Monthly: Price and RSI<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-Price-pattern\" title=\"Weekly: Price pattern\">Weekly: Price pattern<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-MACD\" title=\"Weekly: MACD\">Weekly: MACD<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-Ichimoku\" title=\"Weekly: Ichimoku\">Weekly: Ichimoku<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-Supertrend\" title=\"Weekly: Supertrend\">Weekly: Supertrend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-ratio-chart-Strides-vs-Aarti-Drugs\" title=\"Weekly ratio chart: Strides v\/s Aarti Drugs\">Weekly ratio chart: Strides v\/s Aarti Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-Ratio-chart-Strides-Pharma-vs-Abbott-India\" title=\"Weekly: Ratio chart: Strides Pharma v\/s Abbott India\">Weekly: Ratio chart: Strides Pharma v\/s Abbott India<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Weekly-Ratio-Chart-Strides-Pharma-vs-Advanced-Enzymes\" title=\"Weekly: Ratio Chart: Strides Pharma v\/s Advanced Enzymes\">Weekly: Ratio Chart: Strides Pharma v\/s Advanced Enzymes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.tickertape.in\/blog\/strides-pharma-counter-striving-for-excellence\/#Putting-it-all-together\" title=\"Putting it all together\">Putting it all together<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Monthly-Price-action\"><\/span><strong>Monthly: Price action<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Look at the chart from 2000. The zone highlighted on the chart was a resistance zone until 2014. After 2014, the price crossed the resistance zone on the higher side and made a new debut on the upside. The extremely volatile count reached the 1300 mark, returned to the scene zone, and found a support area. It&#8217;s the third time the same zone is acting as the sport. This polarity change makes the counter more attractive from a favourable risk-reward ratio.&nbsp;<br><img loading=\"lazy\" decoding=\"async\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh5.googleusercontent.com\/MG_n7BIl-6B96ryyJOpXy9VmC-CLVmqLrtaAC-SN0yaXbs-W2qsvX2QKTLgrSmPiq6KwEBmGN67YfcvzK6wXNL9iYK8mDA2YxtzgseiUpK69tpD0iJ7ZflIjPsLePwkQjoelsav8GRlK758ude0WLt6VbNrg2FbO-RfP9uQVFPuPwhBnCDH_nRtltZdfGrTHySD_J1QHPA\" width=\"643\" height=\"303\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-Price-and-volume-action\"><\/span><strong>Weekly: Price and volume action<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Historically, extreme volumes were noticed when the price reached the support zone highlighted with the trendline. The volumes are again picking up near the same zone, making the counter more attractive.&nbsp;<br><img loading=\"lazy\" decoding=\"async\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh5.googleusercontent.com\/kpH719cFSYckXJcXU4I5FbZ77TkQilRbYOpUFncQ5p_efyf6EByi7gMegeW-8Xy5B6gBSEXfGjyM34rDbiBJrgMrB8vRDkx0eF3IHIb_idoTz6x8-bB2ogS7V6fie3OFAaaFQRRMFLD0154T24W297_7xqJncguq7I8rv4jmcycw9NfnVUEzM_GT6apcJiggwjcAsX7OOQ\" width=\"643\" height=\"302\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-Price-and-Fibonacci\"><\/span><strong>Weekly: Price and Fibonacci<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>If we look at the entire advance from 2019 to 2015, the rally was quite steep. Price correction was really severe but exactly halted at 78.6% of the retracement of Fibonacci. Multiple times, it halted at the same level, making that zone very important. Even if someone wishes to buy without breaking out, this zone seems the best zone to accumulate the counter.<br><img loading=\"lazy\" decoding=\"async\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh4.googleusercontent.com\/jvWlrm7BwHF9bjlT7LGjG-fCAjIkayhMs5vWVtpUevhdYxyRZ9wDcRkRBKHFtk_0YqI047apJ1ZuPAGaQfR7biAIw7u1xmIdD3iqeVsT49pjNs7yETY0_3hxFAgOg1JldRW4klttq1tmoM-fVKfXBgYrPwhALTlwgTA341s_cCCK2O66R0g2AebnhYWO3Rka36iwDL_TzQ\" width=\"643\" height=\"304\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Monthly-Price-and-RSI\"><\/span><strong>Monthly: Price and RSI<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/www.tickertape.in\/blog\/relative-strength-index\/\">Relative Strength Index<\/a><strong> (<\/strong>RSI) is a <a href=\"https:\/\/www.tickertape.in\/blog\/momentum-indicator\/\">momentum indicator<\/a>. We can see that the price reached the same zone as a swing before, but RSI is making a higher bottom compared to the previous swing low. This is creating a bullish divergence on the RSI. The stock will be good to go with a consolidation breakout on the chart.&nbsp;<br><img loading=\"lazy\" decoding=\"async\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh4.googleusercontent.com\/poFL8WAkAJ05dTjMF1_2-UnfVMNhg1q2QjegpVbAzr6k0cjNFP4LESe-mIhkFviUWNy0ZOoApB1Fcfj9_D_zibxqK_T6yJZVlOE7cqrPsjMcBKvFY-pE6nPdrtRK-kl7ZL1Mre_Dy2qraHWofVE9MdPT8cMKHCebOfY2ZJavdbO2CIlX7eEVoe1yjptbwvZ1QqrUtztnNQ\" width=\"643\" height=\"304\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-Price-pattern\"><\/span><strong>Weekly: Price pattern<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Along with bullish RSI divergence, we can see price in sideways consolidation. But proper plotting of trendlines highlights inverse head and shoulders formation, which is well supported by volumes. Momentum traders should wait for the breakout as the first sign to trade bullish on the counter.&nbsp;<br><img loading=\"lazy\" decoding=\"async\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh3.googleusercontent.com\/doTo3g-1mEAL33oCGn414RHGP57RN3iCVKyOr5krOn1PyRpER5eLhCV7u4jPLEULnbR0rSjru6pOWHXVFVSqdc_h16kCmjdq1l1LxAayczqjGwxjeRs-WyQVDn3wCxu1SmaJV1PqoRPJW3XlJYozz2kvYN5nkeNYlep8Ud2P-jnnK04rLggh5GCN7rWr09q5QzDC468ufA\" width=\"643\" height=\"304\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-MACD\"><\/span><strong>Weekly: MACD<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Moving Average Convergence\/Divergence (<a href=\"https:\/\/www.tickertape.in\/blog\/moving-average-convergence-divergence\/\">MACD<\/a>) is a lagging indicator and confirms the trend. But this indicator can be seen in multiple ways. Interestingly, MACD made an extreme low below 2015 lows. It started growing when the price was in sideways consolidation. This is making a bullish divergence. This divergence coincides with the MACD crossover right near the low. Once MACD crosses the zero line on the upside, all observations on the indicators will show a thumbs up!<br><img loading=\"lazy\" decoding=\"async\" width=\"643\" height=\"302\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh5.googleusercontent.com\/xF08HyyimoP2vEP6_adh3yhRKUvEhsUiZ-TDpzno_zs7N86z3DLcoujXCgalVZAHMytP3-RuetaIeJvDp7TzznrJkFtigMYazmeMnRkbgtLrO3i3tlRi-PKpeTL0RtxF1bzjVpb0CEFsjJU_3zNXEjeVBC5O1Ikeo8kwJv-10iZy0w_0zEsRNorsdJvCgSVeLvqqvvD-xw\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-Ichimoku\"><\/span><strong>Weekly: Ichimoku<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Ichimoku is a very advanced indicator. I consider this indicator to be one of the best for trend following. So far, all the signs on the indicator are negative. The recent bounce of the price exactly halted at Kumo cloud. Once the price enters the cloud, it will challenge the further downside and will be the first sign of trend reversal.<br><img loading=\"lazy\" decoding=\"async\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh5.googleusercontent.com\/j8uzZV1-Zdx5i84RF7A3rltIcQ8RBd5oi21gge4d_SRJNNkXLRfAHSBmpg_OxGOoI3lQHR37GSXJQ5gywyQGYnbjcceI7xcjiZQTZGUdDnKft7MDnr5w0N5vxyjDY7z-gYTcsfspNilbdrYGx9Z0xr5Lm-BTWULrpDlBMzG3Xf4NYVWZj92zHG_k4HhuxO5PWvUGEIEllA\" width=\"643\" height=\"304\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-Supertrend\"><\/span><strong>Weekly: Supertrend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>It is a trending indicator and offers good support\/resistance during the ongoing rally. The best part of the indicator is its simplicity. A single line without any noise. Very clearly, the price has respected this indicator most of the time. Present resistance is right on the chart. Above super trend, it\u2019s a thumbs up for longs.\u00a0<br><img loading=\"lazy\" decoding=\"async\" width=\"643\" height=\"305\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh3.googleusercontent.com\/qwgay2H8OyL5bjR45TMt2UjH8K2meq6flT8EIue61YRBme7urGmVM_LLBWUkuaJJXVyZfUfoR5U8aR5RpY4GsxQfWml0AyR5h-ZPu5tEYslgfHPNmjO4bn31-SnqVSNBc1QSDLWFyjyoqd3jqLPYCsYz6PHqF1UR3PvEG6LE9oeddNeTMVdyNJOiOLKDuoUR\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-ratio-chart-Strides-vs-Aarti-Drugs\"><\/span><strong>Weekly ratio chart: Strides v\/s Aarti Drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Based on business models, firstly comparing the counter with <a href=\"https:\/\/www.tickertape.in\/stocks\/aarti-drugs-ADRG?checklist=pro&amp;utm_source=blog&amp;utm_medium=gart&amp;utm_campaign=kunram\" target=\"_blank\" data-type=\"URL\" data-id=\"https:\/\/www.tickertape.in\/stocks\/aarti-drugs-ADRG?checklist=pro&amp;utm_source=blog&amp;utm_medium=gart&amp;utm_campaign=kunram\" rel=\"noreferrer noopener\">Aarti Drugs<\/a>. A very clear underperformance is seen on the chart. But at the same time, the ratio chart is in sideways consolidation for 1.5 yrs, forming (kind of) a falling wedge and raising hopes of a bounce. So Strides Pharma may outperform on the breakout.\u00a0<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/lh4.googleusercontent.com\/8TFbJtX0QQlSRl2iutDGLePryixjp_L2aHOXA9uNWzjMyV7-vAQZpfbKGK--h59auI_y1dfwRfhmpWJDD0fvRPHQLHigsiUGAW3grTkYcWKBcyjpzntf2DA9vfZqbFs2DMR9_nmVcqjwM8x5ZHVquMKdENnwztHw56oobTRH9sFRAybd_UE-O9tVwve6kdsj\" alt=\"pasted-image.tiff\"\/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-Ratio-chart-Strides-Pharma-vs-Abbott-India\"><\/span><strong>Weekly: Ratio chart: Strides Pharma v\/s Abbott India<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>On comparing the counter with <a href=\"https:\/\/www.tickertape.in\/stocks\/abbott-india-ABOT?checklist=pro&amp;utm_source=blog&amp;utm_medium=gart&amp;utm_campaign=kunram\" target=\"_blank\" data-type=\"URL\" data-id=\"https:\/\/www.tickertape.in\/stocks\/abbott-india-ABOT?checklist=pro&amp;utm_source=blog&amp;utm_medium=gart&amp;utm_campaign=kunram\" rel=\"noreferrer noopener\">Abbott India<\/a>, the chart is almost similar. Clear underperformance of the counter, but raising hopes due to good support and consolidation near the low. Outperformance is likely on the breakout.<br><img loading=\"lazy\" decoding=\"async\" width=\"643\" height=\"303\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh6.googleusercontent.com\/qPQEJvLXqQbZPbYOoNvh-3zt0bCWNwGwr63RhFoasiQScO50X-exu02S_UKe5s-QTqpg1CQvQGr0wwhV3UTVUK19Ss7_zHVQ0qhmH0ZeBAbYKhx8zTQ4dMhoon66JJ5LPARfaTIXgpEj8cjjtlm0YN2MO3cWg8ywqKHO6626jAw2q-i947btD7YeWgVe9xrn-FCnwapKJA\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Weekly-Ratio-Chart-Strides-Pharma-vs-Advanced-Enzymes\"><\/span><strong>Weekly: Ratio Chart: Strides Pharma v\/s Advanced Enzymes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>This chart is interesting. The ratio chart goes sideways, continues the range, and enters the new range. As of now, it has bounced from the extreme lows, confirming the outperformance of Strides Pharma, but one needs to keep an eye on whether support remains intact. If so, it\u2019s a perfect strength status of Strides Pharma over <a href=\"https:\/\/www.tickertape.in\/stocks\/advanced-enzyme-technologies-ADEN?checklist=pro&amp;utm_source=blog&amp;utm_medium=gart&amp;utm_campaign=kunram\" target=\"_blank\" data-type=\"URL\" data-id=\"https:\/\/www.tickertape.in\/stocks\/advanced-enzyme-technologies-ADEN?checklist=pro&amp;utm_source=blog&amp;utm_medium=gart&amp;utm_campaign=kunram\" rel=\"noreferrer noopener\">Advanced Enzymes<\/a>.&nbsp;<br><img loading=\"lazy\" decoding=\"async\" width=\"643\" height=\"305\" alt=\"pasted-image.tiff\" src=\"https:\/\/lh3.googleusercontent.com\/cPMEqAFnSRDE1sN-xrRMLVf62ByBsCTkUZjMRaDXJtG54RcEy7WHF8IHv0DIsIg_6wWZxSYQFboRkmDMbFsZ9f1PY2fMyCh9xjbHgKPQ2r17lqYGB1chqgm-5Z32BxUjUlhM88dv30mR0_mfnlRlegX7izXJgVCNxRLxsTEU3OgDXut3aLfwzbVLcv9u6d9jw9iVO4ZCgw\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Putting-it-all-together\"><\/span><strong>Putting it all together<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Looking at monthly charts, price actions, price patterns, weekly charts with Fibonacci, MACD, RSI, Super trend, Ichimoku and various ratio charts, it seems that the downside for the counter is very less and one can certainly think of accumulating from the long-term perspective or wait for a breakout to take up momentum trade. Risk reward seems pretty favourable for longs.&nbsp;<\/p>\n\n\n\n<p>Statutory disclosure: Kindly note that this update is only for educational purpose. It is safe to assume that my personal position, my fund\u2019s position, my client\u2019s position and my relative\u2019s position may be open in the counter. Prefer to take the advice of your financial advisor before initiating any position.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Strides Pharma is offering the best risk-reward and is available at a huge discount, says our expert Kunal Rambhia. Read the technical analysis on Strides Pharma.  <\/p>\n","protected":false},"author":73,"featured_media":11100,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_lmt_disableupdate":"no","_lmt_disable":"no","footnotes":""},"categories":[1770],"tags":[],"acf":[],"modified_by":null,"jetpack_featured_media_url":"https:\/\/www.tickertape.in\/blog\/wp-content\/uploads\/2022\/11\/22-Nov-22-Strides-Pharma_Kunal-02-02.png?wsr","_links":{"self":[{"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/posts\/11097"}],"collection":[{"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/users\/73"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/comments?post=11097"}],"version-history":[{"count":3,"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/posts\/11097\/revisions"}],"predecessor-version":[{"id":11105,"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/posts\/11097\/revisions\/11105"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/media\/11100"}],"wp:attachment":[{"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/media?parent=11097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/categories?post=11097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tickertape.in\/blog\/wp-json\/wp\/v2\/tags?post=11097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}